Related News about herpes: Latest studies and research.
In a recent publication in the Journal of Applied Microbiology, a comprehensive analysis was performed on laboratory studies that emphasize the effectiveness of cannabis in combating the impact of viral infections. These infections include severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),…
In the hidden recesses of our nerve cells, approximately 3.7 billion individuals harbor the herpes simplex-1 virus, awaiting the moment it is awakened by stress or physical trauma. Once awakened, it tends to manifest itself in very mild forms, usually…
The FDA has extended the review period for GSK’s Sierra Oncology myelofibrosis drug, momelotinib, through September 2023. GSK, a leading UK-based pharmaceutical company, recently announced that the US Food and Drug Administration (FDA) has decided to extend the duration of…
The Japanese Ministry of Health, Labor and Welfare (MHLW) has indicated a new indication for GlaxoSmithKline’s (GSK) herpes vaccine Shingrix (recombinant herpes vaccine, adjuvanted [RZV]). This vaccine is for adults 18 years of age and older who are most at…
The Ultimate Herpes Protocol is a step-by step blueprint to fight off herpes type I & II as well as shingles without unleashing chemical warfare on your body. Best news: It works even if you’ve already blown hundreds or even thousands of…
We explored statistics on HSV-2 herpes in the United States, highlighting information about the number of affected individuals, distribution by gender, symptoms and outbreaks, transmission rates, and statistics in specific populations. Number of individuals infected with HSV-2 genital herpes in…
